Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy.

This study assessed the ability of vibrational spectroscopy combined with multivariate analysis to quantify ternary mixtures of different solid-state forms, including the amorphous form. Raman and near-infrared spectroscopy were used to quantify mixtures of alpha-, gamma-, and amorphous indomethacin. Partial least squares regression was employed to create quantitative models. To improve the model performance various pre-treatment algorithms and scaling methods were applied to the spectral data and different spectral regions were tested. Standard normal variate transformation and scaling by mean centering proved to be the best approaches to pre-process the data. With four partial least squares factors, root mean square errors of prediction ranging from 5.3% to 6.5% for Raman spectroscopy and 4.0% to 5.9% for near-infrared spectroscopy were calculated. In addition, the effects of potential sources of error were investigated. Sample fluorescence predominantly caused by yellow amorphous indomethacin was observed to have a significant impact on the Raman spectra. Nevertheless, this source of error could be minimized in the quantitative models. Sample inhomogeneity, particularly in conjunction with a small sampling area when stationary sample holders were used, introduced the largest variation into both spectroscopic assays. The overall method errors were found to be very similar, resulting in relative standard deviations up to 12.0% for Raman spectroscopy and up to 13.0% for near-infrared spectroscopy. The results show that both spectroscopic techniques in combination with multivariate modeling are well suited to rapidly quantify ternary mixtures of crystalline and amorphous indomethacin. Furthermore, this study shows that quantitative analysis of powder mixtures using Raman spectroscopy can be performed in the presence of limited fluorescence.

[1]  L Yu,et al.  Amorphous pharmaceutical solids: preparation, characterization and stabilization. , 2001, Advanced drug delivery reviews.

[2]  J. Sjöblom,et al.  Quantitative FT-Raman analysis of two crystal forms of a pharmaceutical compound. , 1997, Journal of pharmaceutical and biomedical analysis.

[3]  M. Otsuka,et al.  Evaluation of the Microcrystallinity of a Drug Substance, Indomethacin, in a Pharmaceutical Model Tablet by Chemometric FT-Raman Spectroscopy , 2005, Pharmaceutical Research.

[4]  L. S. Taylor,et al.  Evaluation of solid-state forms present in tablets by Raman spectroscopy. , 2000, Journal of pharmaceutical sciences.

[5]  K R Morris,et al.  Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. , 2001, Advanced drug delivery reviews.

[6]  D. Bugay,et al.  Quantitation of cefepime.2HCl dihydrate in cefepime.2HCl monohydrate by diffuse reflectance IR and powder X-ray diffraction techniques. , 1996, Journal of pharmaceutical and biomedical analysis.

[7]  G A Stephenson,et al.  Characterization of the solid state: quantitative issues. , 2001, Advanced drug delivery reviews.

[8]  H. Siesler,et al.  Near-infrared spectroscopy:principles,instruments,applications , 2002 .

[9]  Richard L. McCreery,et al.  Raman Spectroscopy for Chemical Analysis , 2000 .

[10]  Bruno C. Hancock,et al.  Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. , 1994, Journal of pharmaceutical sciences.

[11]  Bruno C. Hancock,et al.  What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.

[12]  J. Rantanen,et al.  Improved Understanding of Factors Contributing to Quantification of Anhydrate/Hydrate Powder Mixtures , 2005, Applied spectroscopy.

[13]  Thomas Rades,et al.  Quantitative analysis of polymorphic mixtures of carbamazepine by Raman spectroscopy and principal components analysis , 2004 .

[14]  R. J. Lehnert,et al.  The dependence of Raman signal intensity on particle size for crystal powders , 1996 .

[15]  C. Casolino,et al.  Application of standardisation methods to correct the spectral differences induced by a fibre optic probe used for the near-infrared analysis of pharmaceutical tablets. , 1998, Journal of pharmaceutical and biomedical analysis.

[16]  G. Zografi,et al.  Crystal nucleation and growth of indomethacin polymorphs from the amorphous state , 2000 .

[17]  Desire L. Massart,et al.  Investigation of sources of variance which contribute to NIR-spectroscopic measurement of pharmaceutical formulations , 1997 .

[18]  Jonas Johansson,et al.  Infrared imaging of laser-induced heating during Raman spectroscopy of pharmaceutical solids. , 2002, Journal of pharmaceutical and biomedical analysis.

[19]  N. Kaneniwa,et al.  Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol. , 1985, Chemical & pharmaceutical bulletin.

[20]  Nils-Olof Lindberg,et al.  Multivariate methods in pharmaceutical applications , 2002 .

[21]  R. Barnes,et al.  Standard Normal Variate Transformation and De-Trending of Near-Infrared Diffuse Reflectance Spectra , 1989 .

[22]  P. Cox,et al.  γ‐Indomethacin at 120 K , 2003 .

[23]  Lynne S. Taylor,et al.  Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions , 1997, Pharmaceutical Research.

[24]  M. Pelletier,et al.  Quantitative Analysis Using Raman Spectrometry , 2003, Applied spectroscopy.

[25]  T. Nagai,et al.  Stability and several physical properties of amorphous and crystalline form of indomethacin. , 1980, Chemical & pharmaceutical bulletin.

[26]  K. Morris,et al.  Raman spectroscopy for tablet coating thickness quantification and coating characterization in the presence of strong fluorescent interference. , 2006, Journal of pharmaceutical and biomedical analysis.

[27]  R. D. Jee,et al.  The application of multiple linear regression to the measurement of the median particle size of drugs and pharmaceutical excipients by near-infrared spectroscopy. , 1998, The Analyst.

[28]  D. Grant THEORY AND ORIGIN OF POLYMORPHISM , 1999 .

[29]  G. Zografi,et al.  The Quantitative Analysis of Crystallinity Using FT-Raman Spectroscopy , 1998, Pharmaceutical Research.

[30]  Steven W Booth,et al.  Quantitative analysis of mannitol polymorphs. FT-Raman spectroscopy. , 2002, Journal of pharmaceutical and biomedical analysis.

[31]  T. Vickers,et al.  Effect of Powder Properties on the Intensity of Raman Scattering by Crystalline Solids , 2002 .

[32]  D. Bugay,et al.  Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms. , 1998, Journal of pharmaceutical and biomedical analysis.

[33]  N Kaneniwa,et al.  A kinetic study of the crystallization process of noncrystalline indomethacin under isothermal conditions. , 1988, Chemical & pharmaceutical bulletin.

[34]  K. Morris,et al.  Reactivity differences of indomethacin solid forms with ammonia gas. , 2002, Journal of the American Chemical Society.

[35]  P. Geladi,et al.  Linearization and Scatter-Correction for Near-Infrared Reflectance Spectra of Meat , 1985 .

[36]  Erik Johansson,et al.  Mixture design—design generation, PLS analysis, and model usage , 1998 .

[37]  H. Brittain Polymorphism in Pharmaceutical Solids , 1999 .

[38]  J. Curcio,et al.  Near infrared absorption spectrum of liquid water , 1951 .

[39]  M. Otsuka,et al.  Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry. , 2001, The Analyst.

[40]  D. Bugay Characterization of the solid-state: spectroscopic techniques. , 2001, Advanced drug delivery reviews.

[41]  A. Savitzky,et al.  Smoothing and Differentiation of Data by Simplified Least Squares Procedures. , 1964 .

[42]  R. E. Marsh,et al.  Crystal and molecular structure of an antiinflammatory agent, indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid. , 1972, Journal of the American Chemical Society.

[43]  S. Wold,et al.  PLS-regression: a basic tool of chemometrics , 2001 .